Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.3109/08923973.2015.1077461 http://scihub22266oqcxt.onion/10.3109/08923973.2015.1077461 C4819877!4819877!26525648     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26525648.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Immunopharmacol+Immunotoxicol 2016 ; 38 (1): 14-20 Nephropedia Template TP {{tp|p=26525648|t=2016. Detection of autoantibodies using chemiluminescence technologies |pdf=|usr=}}{{26525648}} gab.com Text Detection of autoantibodies using chemiluminescence technologies JO: Immunopharmacol Immunotoxicol http://www.kidney.de/pget.php?&tw=1&pmid=26525648 #FOAvip Context: Although autoantibody detection methods such as indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assays (ELISAs) have been available for many years and are still in use the innovation of fast, fully automated instruments using chemiluminescence technology in recent years has led to rapid adoption in autoimmune disease diagnostics. In 2009, BIO-FLASH, a fully automated, random access chemiluminescent analyzer, was introduced, proceeded by the development of the QUANTA Flash chemiluminescent immunoassays (CIA) for autoimmune diagnostics.Objective: To summarize the evolution of CIAs for the detection of autoantibodies and to review their performance characteristics.Methods: Pubmed was screened for publications evaluating novel QUANTA Flash assays and how they compare to traditional methods for the detection of autoantibodies. In addition, comparative studies presented at scientific meetings were summarized.Results: Several studies were identified that compared the novel CIAs with conventional methods for autoantibody detection. The agreements ranged from moderate to excellent depending on the assay. The studies show how the CIA technology has enhanced the analytical and clinical performance characteristics of many autoantibody assays supporting both diagnosis and follow-up testing.Conclusion: CIA has started to improve the diagnostic testing of autoantibodies as an aid in the diagnosis of a broad range of autoimmune diseases. Twit Text FOAVip Detection of autoantibodies using chemiluminescence technologies ????Immunopharmacol Immunotoxicol http://www.kidney.de/pget.php?&tw=1&pmid=26525648 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26525648 #FOAvip English Wikipedia <ref>{{Cite pmid|26525648}}</ref> Detection of autoantibodies using chemiluminescence technologies #MMPMID26525648 Mahler M; Bentow C; Serra J; Fritzler MJ Immunopharmacol Immunotoxicol 2016[Jan]; 38 (1): 14-20 PMID26525648show ga Context: Although autoantibody detection methods such as indirect immunofluorescence (IIF) and enzyme-linked immunosorbent assays (ELISAs) have been available for many years and are still in use the innovation of fast, fully automated instruments using chemiluminescence technology in recent years has led to rapid adoption in autoimmune disease diagnostics. In 2009, BIO-FLASH, a fully automated, random access chemiluminescent analyzer, was introduced, proceeded by the development of the QUANTA Flash chemiluminescent immunoassays (CIA) for autoimmune diagnostics.Objective: To summarize the evolution of CIAs for the detection of autoantibodies and to review their performance characteristics.Methods: Pubmed was screened for publications evaluating novel QUANTA Flash assays and how they compare to traditional methods for the detection of autoantibodies. In addition, comparative studies presented at scientific meetings were summarized.Results: Several studies were identified that compared the novel CIAs with conventional methods for autoantibody detection. The agreements ranged from moderate to excellent depending on the assay. The studies show how the CIA technology has enhanced the analytical and clinical performance characteristics of many autoantibody assays supporting both diagnosis and follow-up testing.Conclusion: CIA has started to improve the diagnostic testing of autoantibodies as an aid in the diagnosis of a broad range of autoimmune diseases. äDetection of autoantibodies using chemiluminescence technologies (epmc).pdf DeepDyve Pubget Overpricing